Aerobic Exercise for Breast Cancer Survivors
(ROME Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how aerobic exercise affects the gut health of women who have survived breast cancer. Researchers aim to determine if changes in gut health can reduce symptoms like fatigue. Participants will either engage in supervised aerobic exercise sessions (known as Aerobic Exercise Training) or participate in non-aerobic activities for comparison. Women who completed their primary breast cancer treatment at least a year ago and experience frequent fatigue might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to understanding how lifestyle changes can improve post-cancer health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that you do not change your usual medications during the study period.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that aerobic exercise is generally safe for breast cancer survivors. It can help reduce treatment-related side effects and improve quality of life. One study found that moderate-to-high intensity aerobic exercise, when supervised, is safe and can lead to better health outcomes.
Overall, exercise is recommended for cancer survivors. It is a safe activity that offers many health benefits, making it a good option for those looking to improve fitness and well-being.12345Why are researchers excited about this trial?
Researchers are excited about aerobic exercise training for breast cancer survivors because it offers a unique, non-invasive way to potentially improve health outcomes beyond traditional treatments like surgery, chemotherapy, and hormonal therapy. Unlike these standard options, which primarily target cancer cells, aerobic exercise focuses on enhancing overall physical fitness, reducing fatigue, and improving quality of life. The supervised, progressive nature of these exercise sessions, facilitated by specialists experienced in working with cancer survivors, ensures that participants receive personalized, safe, and effective training. By exploring this approach, researchers hope to uncover additional benefits that go hand-in-hand with existing cancer treatments.
What evidence suggests that aerobic exercise training could be effective for breast cancer survivors?
Research has shown that aerobic exercise, which participants in this trial may receive, can greatly benefit breast cancer survivors. Studies have found that it boosts energy levels and improves physical abilities, enhancing quality of life. Exercise also reduces cancer-related fatigue, a common issue after treatment. Additionally, aerobic exercise helps maintain a healthy weight and improves heart and lung health. Overall, regular aerobic activity plays a crucial role in recovery and well-being.13678
Who Is on the Research Team?
Laura Q Rogers, MD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for women aged 18-74 who are breast cancer survivors (stage 0, I, II, or III) and have been free from primary treatment for at least a year. Participants should not be taking probiotics or antibiotics recently, must be able to walk without help, have low exercise capacity, experience fatigue, and get medical clearance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exercise Training
Participants undergo 10 weeks of progressive aerobic exercise training supervised by exercise specialists
Follow-up
Participants are monitored for changes in gut microbiota, fatigue, and other physiological and psychosocial measures
What Are the Treatments Tested in This Trial?
Interventions
- Aerobic Exercise Training
- Attention Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Cancer Institute (NCI)
Collaborator